Brief: Rani Therapeutics Holdings Inc Says On January 6, Rani Therapeutics, Llc, Operating Unit Co And Celltrion, Inc. Entered Into License And Supply Agreement

Rani Therapeutics Holdings

09/01/2023 13:55

Jan 9 (Reuters) - Rani Therapeutics Holdings Inc
 RANI.O :
    * RANI THERAPEUTICS HOLDINGS INC - ON JANUARY 6, RANI
THERAPEUTICS, LLC, OPERATING UNIT CO AND CELLTRION, INC. ENTERED
INTO LICENSE AND SUPPLY AGREEMENT
    * RANI THERAPEUTICS HOLDINGS INC- CELLTRION GRANTS CO
LICENSE TO
CERTAIN IP FOR AN ORALLY-ADMINISTERED THERAPEUTIC PRODUCT
    * RANI THERAPEUTICS HOLDINGS-CO WILL OBTAIN USTEKIUNMAB
BIOSIMILAR
EXCLUSIVELY FROM CELLTRION FOR MANUFACTURE, DEVELOPMENT,
COMMERCIALIZATION OF PRODUCT
    * RANI THERAPEUTICS HOLDINGS-CELLTRION WILL PROVIDE, CO WILL
PURCHASE, SUPPLY OF USTEKINUMAB BIOSIMILAR AT SUPPLY PRICES SET
FORTH IN LICENSE AGREEMENT

Source text for Eikon:  ID: 
Further company coverage:  RANI.O 
 ((reuters.briefs@thomsonreuters.com;))